Cutimum (Calcipotriol + Betamethasone) Gel

What Is Cutimum and What Is It Used For?

Cutimum is a prescription topical gel used to treat plaque psoriasis (psoriasis vulgaris) in adults. It contains two active ingredients — calcipotriol (a synthetic vitamin D3 analogue) and betamethasone dipropionate (a potent corticosteroid) — that work together to control the overproduction of skin cells, reduce inflammation, and relieve itching and scaling.

Psoriasis is a chronic autoimmune condition that affects approximately 2–3% of the global population, according to the World Health Organization (WHO). It causes the immune system to trigger excessive skin cell production, leading to the formation of thick, red, scaly patches known as plaques. These plaques can appear anywhere on the body but are most commonly found on the elbows, knees, scalp, and lower back.

Cutimum addresses psoriasis through two complementary mechanisms. Calcipotriol, the vitamin D3 analogue component, works by binding to vitamin D receptors in keratinocytes (skin cells). This binding inhibits the abnormally rapid proliferation of keratinocytes that characterizes psoriasis and simultaneously promotes their normal differentiation and maturation. By normalizing the skin cell life cycle, calcipotriol helps to reduce the thickness and scaling of psoriatic plaques.

Betamethasone dipropionate, a group III potent corticosteroid, provides powerful anti-inflammatory and immunosuppressive effects. It suppresses the release of inflammatory mediators, reduces the dilation of blood vessels in the affected area (thereby decreasing redness), and inhibits the migration of immune cells into the psoriatic plaque. This anti-inflammatory action provides rapid relief from the itching, redness, and discomfort associated with psoriasis.

Clinical trials have demonstrated that the combination of calcipotriol and betamethasone dipropionate is significantly more effective than either active ingredient used alone. A Cochrane systematic review found that the combination product achieved complete or near-complete clearance of psoriatic plaques in a substantially higher proportion of patients compared to monotherapy with either component. The gel formulation of Cutimum provides the additional advantage of being cosmetically elegant, non-greasy, and easy to spread over affected areas, making it particularly suitable for treating psoriasis on the body and scalp.

What Should You Know Before Using Cutimum?

Before using Cutimum, inform your doctor about any allergies, skin infections, or other medical conditions. Cutimum should not be used in certain skin conditions, and special care is needed during pregnancy or breastfeeding. Understanding the contraindications and precautions will help ensure safe and effective treatment.

Contraindications

Cutimum gel should not be used if you have any of the following conditions:

• Hypersensitivity: Known allergy to calcipotriol, betamethasone dipropionate, or any of the excipients (inactive ingredients) in the gel
• Viral skin infections: Such as herpes simplex (cold sores), varicella (chickenpox), or vaccinia (cowpox)
• Fungal skin infections: Including tinea (ringworm), candidiasis, or other fungal infections at the treatment site
• Bacterial skin infections: Such as impetigo or cellulitis at the application site
• Parasitic skin infections: Such as scabies at the application site
• Skin manifestations of tuberculosis or syphilis
• Perioral dermatitis: Inflammation around the mouth
• Acne vulgaris, rosacea, or acne rosacea
• Skin atrophy, striae (stretch marks), or fragile skin veins at the treatment site
• Ichthyosis, ulcerated skin, or perianal and genital itching
• Guttate, erythrodermic, exfoliative, or pustular psoriasis (these forms require different treatment approaches)
• Disorders of calcium metabolism: Such as hypercalcemia or conditions where calcium homeostasis is disturbed
• Severe kidney or liver disease: Which may impair the metabolism of the active ingredients

Warnings and Precautions

Several important precautions should be observed when using Cutimum gel to ensure safety and effectiveness:

• Avoid the face and skin folds: The skin on the face, armpits, groin, and under the breasts is thinner and more sensitive to corticosteroids, increasing the risk of skin thinning (atrophy), stretch marks (striae), and visible small blood vessels (telangiectasia)
• Do not use under occlusive dressings: Covering the treated area with airtight bandages increases absorption of the corticosteroid and may lead to systemic effects
• Do not exceed 100 g per week: Using excessive amounts increases the risk of systemic absorption of betamethasone, which can suppress the hypothalamic-pituitary-adrenal (HPA) axis and cause calcium disturbances from calcipotriol
• Avoid eyes: If Cutimum accidentally comes into contact with the eyes, rinse immediately with plenty of water. Prolonged exposure of the eye area to corticosteroids can increase the risk of glaucoma and cataracts
• Monitor for infection: If a secondary bacterial or fungal infection develops at the treatment site, appropriate antimicrobial therapy should be initiated. If the infection worsens, Cutimum should be discontinued until the infection is controlled
• Rebound effect: Abrupt discontinuation after prolonged use may cause a rebound flare of psoriasis. Your doctor may recommend gradually reducing the frequency of application
• Phototherapy: If you are also receiving UV light therapy (phototherapy) for psoriasis, discuss with your doctor, as combining topical treatments with UV exposure may increase skin sensitivity

Pregnancy and Breastfeeding

The use of Cutimum during pregnancy and breastfeeding requires careful consideration and should be discussed with your healthcare provider:

Pregnancy: There are limited data on the use of calcipotriol-betamethasone combination products in pregnant women. Animal studies with corticosteroids have shown teratogenic effects (birth defects) when administered systemically at high doses, including cleft palate and growth restriction. However, topical application results in significantly lower systemic exposure. The European Medicines Agency (EMA) advises that Cutimum should only be used during pregnancy if the expected benefit to the mother outweighs the potential risk to the fetus. If treatment is deemed necessary, it should be limited to the smallest area and shortest duration possible.

Breastfeeding: It is not known whether calcipotriol or betamethasone dipropionate are excreted in human breast milk following topical application. As a precaution, Cutimum should not be applied to the breast area during breastfeeding to avoid accidental ingestion by the infant. The potential risk to the nursing infant should be weighed against the benefit of treatment for the mother. If used during breastfeeding, apply to a limited area and wash hands thoroughly after application.

Fertility: No specific studies on the effects of Cutimum on human fertility have been conducted. Animal studies with calcipotriol and betamethasone individually have not revealed any negative effects on fertility at clinically relevant doses.

How Does Cutimum Interact with Other Drugs?

Cutimum gel has relatively few drug interactions due to its topical route of administration, which limits systemic absorption. However, certain combinations should be avoided or managed carefully. Always inform your doctor about all medications you are currently using, including other topical products, oral medications, and supplements.

Because Cutimum is applied topically to the skin, systemic absorption is generally low, and the risk of significant drug interactions is limited compared to oral medications. However, several potential interactions should be considered:

Major Interactions

The most clinically significant interaction to be aware of is the concurrent use of other topical corticosteroids on the same body area. Using multiple corticosteroid products simultaneously greatly increases the risk of local side effects such as skin atrophy (thinning), striae (stretch marks), and telangiectasia (visible small blood vessels). It also raises the possibility of systemic corticosteroid absorption, which can suppress the body's natural cortisol production through HPA axis suppression. If you are prescribed other corticosteroid-containing products for different skin conditions, ensure you do not apply them to the same areas where Cutimum is being used.

Minor Interactions

Emollients and moisturizers are commonly used alongside psoriasis treatments to keep the skin hydrated and reduce flaking. While not a harmful interaction, applying an emollient at the same time as Cutimum can dilute the active ingredients or create a barrier that affects absorption. For optimal results, apply Cutimum first and wait at least 30 minutes before applying moisturizer, or apply the moisturizer well in advance of the Cutimum application. Similarly, salicylic acid — often used as a keratolytic to remove scales before applying other treatments — has been shown to chemically inactivate calcipotriol, so these products should be applied at different times of the day.

What Is the Correct Dosage of Cutimum?

Cutimum gel is typically applied once daily to affected psoriatic areas. The initial treatment course should not exceed 4 weeks of continuous use. The maximum recommended weekly amount is 100 g. Your doctor will tailor the dosage to the severity and extent of your psoriasis.

Adults

Children

Elderly

Missed Dose

If you forget to apply Cutimum at your usual time, apply it as soon as you remember on the same day. However, if it is almost time for your next scheduled application, skip the missed dose entirely and resume your regular application schedule the following day. Do not apply a double amount to compensate for a missed application, as this increases the risk of local side effects without providing additional therapeutic benefit.

Occasional missed applications are unlikely to significantly impact your overall treatment outcome. However, consistent daily application during the initial 4-week treatment phase provides the best results. If you frequently forget your applications, consider setting a daily reminder or incorporating the application into an existing daily routine (such as after your evening shower).

Overdose

Topical overdose with Cutimum — for example, applying excessively thick layers or using more than the recommended 100 g per week — may lead to:

• Hypercalcemia: Excessive calcipotriol absorption can elevate serum calcium levels. Symptoms include nausea, vomiting, constipation, muscle weakness, excessive thirst, and confusion. Hypercalcemia is reversible upon discontinuation of the product and usually normalizes within a few days.
• HPA axis suppression: Excessive corticosteroid absorption can suppress the body's natural cortisol production. This is usually reversible but may require gradual dose tapering under medical supervision.
• Local skin damage: Overuse can accelerate skin thinning, development of stretch marks, and visible blood vessels at the application site.

If you suspect you have used too much Cutimum or experience any of the symptoms described above, contact your doctor or pharmacist for advice. In the case of accidental ingestion of the gel, contact your local poison control centre immediately.

What Are the Side Effects of Cutimum?

Like all medicines, Cutimum can cause side effects, although not everybody gets them. The most common side effects are mild and localized to the application site, including itching, skin irritation, and a burning sensation. Serious systemic side effects are rare with proper use but can occur with excessive or prolonged application.

Side effects are classified below by frequency, according to the following convention used by the European Medicines Agency (EMA):

Most side effects associated with Cutimum are local and mild, occurring at or near the site of application. The itching and burning sensation are most commonly reported during the first few days of treatment and typically diminish as the skin adjusts to the medication. If these symptoms persist or worsen, consult your doctor, as the treatment may need to be temporarily paused or an alternative considered.

Skin atrophy (thinning) is the most important potential long-term side effect and is primarily associated with prolonged or excessive use of the betamethasone component. To minimize this risk, adhere strictly to the recommended treatment duration (maximum 4 weeks continuous use) and maximum weekly amount (100 g). Skin thinning is usually reversible if the product is discontinued before severe changes develop, but advanced atrophy with visible striae may be permanent.

If you experience any side effects not listed here, or if any of the listed side effects become severe, please report them to your doctor, pharmacist, or your national adverse drug reaction reporting system. Reporting side effects helps regulatory authorities monitor the safety of medicines and contributes to improved patient safety.

How Should You Store Cutimum?

Store Cutimum gel at room temperature (below 25°C / 77°F) in its original packaging, away from direct sunlight and heat. Keep the tube tightly closed when not in use. Do not freeze. Keep out of the sight and reach of children.

Proper storage of Cutimum gel is essential to maintain its effectiveness and safety throughout the shelf life. Follow these storage guidelines:

• Temperature: Store below 25°C (77°F). Do not refrigerate or freeze the gel, as extreme temperatures may alter the consistency and stability of the formulation
• Light protection: Keep the tube in its original carton when not in use to protect the active ingredients from degradation by light. Calcipotriol is sensitive to light and heat
• Tube closure: Always replace the cap tightly after each use to prevent the gel from drying out and to maintain hygienic conditions
• Shelf life: Do not use Cutimum after the expiry date printed on the tube and carton (indicated as EXP). The expiry date refers to the last day of that month
• After first opening: Once opened, the gel should typically be used within 12 months. Check the product labelling for the specific in-use shelf life after first opening
• Children: Keep out of the sight and reach of children at all times
• Disposal: Do not dispose of medicines via household waste or wastewater. Ask your pharmacist about appropriate disposal methods for medicines you no longer need. These measures help protect the environment

If you notice any change in the appearance, colour, or consistency of the gel (for example, if it has become unusually watery, discoloured, or has an unusual odour), do not use it. Dispose of the tube appropriately and obtain a new supply from your pharmacy.

What Does Cutimum Contain?

Each gram of Cutimum gel contains calcipotriol 25 micrograms (as calcipotriol monohydrate) and betamethasone 0.5 mg (as betamethasone dipropionate) as active ingredients, along with several excipients that form the gel base.

The composition of Cutimum gel is carefully formulated to ensure stability of both active ingredients and optimal delivery to the skin:

Active ingredients (per gram):

• Calcipotriol monohydrate equivalent to calcipotriol 25 micrograms (0.025 mg) — a synthetic vitamin D3 analogue that regulates skin cell growth and differentiation
• Betamethasone dipropionate equivalent to betamethasone 0.5 mg — a potent (group III) topical corticosteroid with anti-inflammatory and immunosuppressive properties

Excipients (inactive ingredients):

The gel base typically contains excipients such as liquid paraffin, polyoxypropylene-11 stearyl ether, hydrogenated castor oil, butylhydroxytoluene (BHT, an antioxidant), and all-rac-alpha-tocopherol (vitamin E, used as a stabilizer). The exact excipient composition may vary by manufacturer and market. For the complete excipient list specific to your product, refer to the patient information leaflet included with your medication.

Frequently Asked Questions About Cutimum

References

About Our Medical Editorial Team